2 completed, 1 active not recruiting. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Dermatitis, Allergic Contact: new trials by email Literature Review of Dermatitis, Allergic Contact trials Research Report on Dermatitis, Allergic Contact
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation Squaric Acid Dibutyl Ester, Known patch test allergens, Dupilumab - Skin Inflammation, Allergic Contact Dermatitis | Phase 2 / Phase 3 | Active not recruiting | Wei-Che Ko | 45 | 2022-11-15 | 2026-06-09 |
| The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis Anakinra, Sodium Chloride 9mg/ml Injection - Allergic Contact Dermatitis | Phase 3 | Completed | Herlev and Gentofte Hospital | 20 | 2022-10-11 | 2025-05-20 |
| Study to Find Out if Cream V61-044 Used to Treat Fungal Infections Causes an Allergic Skin Reaction to Sunlight in Healthy Participants Butenafine HCl 1% (BAY1896425) - Induction Phase, Butenafine HCl 1% (BAY1896425) - Challenge Phase - Dermatitis, Photoallergic | Phase 3 | Completed | Bayer | 137 | 2013-06-10 | 2020-11-16 |
Dermatitis (1) · Dermatitis, Photoallergic (1)
Dermatitis, Contact (3) · Hypersensitivity (3) · Hypersensitivity, Delayed (3) · Immune System Diseases (3) · Skin Diseases (3) · Skin Diseases, Eczematous (3) · Skin and Connective Tissue Diseases (3) · Dermatitis (2) · Photosensitivity Disorders (1)
Adalimumab (1) · Betamethasone Valerate (1) · Fluticasone (1) · Interleukin 1 Receptor Antagonist Protein (1) · Sodium Chloride (1) · Triamcinolone Acetonide (1) · Ustekinumab (1) · butenafine (1) · canakinumab (1) · dupilumab (1) · guselkumab (1) · sarilumab (1) · squaric acid dibutyl ester (1)
Bayer (1) · Herlev and Gentofte Hospital (1) · Wei-Che Ko (1)
United States (2) · Denmark (1)
Wei-Che Ko, MD (1)